MICHELE COMPTON: Open Payments
NPI 1629103536 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 54 payments from 16 companies in 2025. Trend: 2023 $1,380 · 2024 $1,136 · 2025 $991
Food & beverage: $891Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $276 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $210 |
| UCB, Inc. | 4 | $89 |
| Janssen Biotech, Inc. | 3 | $78 |
| Organon LLC | 5 | $61 |
| Galderma Laboratories, L.P. | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $35 |
| Organogenesis Inc. | 1 | $24 |
Products named: SKYRIZI, RINVOQ, Bimzelx, TREMFYA, ILUMYA, DUPIXENT, NEMLUVIO, BLU-U.
Industry payments across DE — which companies pay providers there.
